0001062993-22-008797.txt : 20220328 0001062993-22-008797.hdr.sgml : 20220328 20220328193810 ACCESSION NUMBER: 0001062993-22-008797 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220328 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39271 FILM NUMBER: 22776991 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Renovacor, Inc. CENTRAL INDEX KEY: 0001799850 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 8142 CITY: GREENWICH STATE: CT ZIP: 06836 BUSINESS PHONE: 610-424-2650 MAIL ADDRESS: STREET 1: P.O. BOX 8142 CITY: GREENWICH STATE: CT ZIP: 06836 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition 2 Corp. DATE OF NAME CHANGE: 20200306 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition III Corp. DATE OF NAME CHANGE: 20200113 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-03-28 0001799850 Renovacor, Inc. RCOR 0001129890 DRISCOLL FREDERICK W RENOVACOR, INC. P.O. BOX 8142 GREENWICH CT 06836 0 1 0 0 Chief Financial Officer Option 4.30 2022-03-28 4 A 0 155325 0 A 2032-03-28 Common Stock 155325 155325 D The stock option will vest and become exercisable in full on March 28, 2026, with 25% vesting on March 28, 2023, and the remainder vesting in equal monthly installments for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting date. /s/ Joseph Carroll, as attorney-in-fact 2022-03-28